COMMUNIQUÉS West-GlobeNewswire

ERPSI Wins $96,212,866 Recompete to Provide DevOps Support to U.S. Citizenship and Immigration Services (USCIS)
24/06/2019
Team Will Continue to Deliver Services to Strengthen Mission of Department of Homeland Security ARLINGTON, Va., June 24, 2019 (GLOBE NEWSWIRE) -- The Department of Homeland Security (DHS), U.S. Citizenship and [...]
FWD Pharma Conference 2019 to Transform Digital Journey of Biotech, Life Science Sectors
24/06/2019
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- There’s an exciting buildup underway for the FWD Pharma Conference , slated to be held Aug. 6-8, 2019, at the Doubletree by Hilton Hotel Philadelphia [...]
UBQU Redoubles HempLife Today™ Business Initiatives To Catalyze Accelerated Growth
24/06/2019
DENVER, June 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Ubiquitech Software Corp. (OTC: UBQU), through its subsidiary HempLife Today™, is releasing a complete mid year review for 2019, and into 2020. This update [...]
PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
24/06/2019
HONG KONG, June 24, 2019 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics Co., Ltd. (AmoyDx) and [...]
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
24/06/2019
LAVAL, Québec, June 24, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Oncology Venture gets European patent on its AI powered method to find patients who will benefit from LiPlaCis
24/06/2019
Press release Hoersholm, Denmark, June 24, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today informs that the European Patent Office will grant Oncology Venture a patent on the LiPlaCis Drug [...]
Novo Nordisk A/S – Share repurchase programme
24/06/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 24 June 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]
MyoKardia Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy
24/06/2019
Continuous Monitoring with Wearable Device Detected Distinct Pulse Wave Patterns in Obstructive Hypertrophic Cardiomyopathy Patients as Compared to Healthy Volunteers SOUTH SAN FRANCISCO, Calif., June 24, 2019 (GLOBE [...]
Independent Readers Using Progenics’ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI
24/06/2019
Oral Presentation of Progenics’ PSMA AI Technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ [...]
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Unique Aspects of the Company’s GRAIN Technology Platform to Identify Novel Traits for Crops at the 3rd Precision CRISPR & NBT AgBio Congress
24/06/2019
WOBURN, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser
24/06/2019
New clinical data highlight convenience, efficiency, and safety of Obalon’s proprietary Navigation and Touch Dispenser systems to achieve reliable balloon administration without the use of x-ray SAN DIEGO, June 24, 2019 [...]
Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans
24/06/2019
MIRAMAR, Fla., June 24, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the audio recording of its investor [...]
Novelion Therapeutics Responds to Whitefort Capital Petition
24/06/2019
VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019
24/06/2019
TUSTIN, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]
Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical Officer
24/06/2019
HAMPTON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced the appointment of Diane C. Young, M.D., as Senior Vice President, Chief Medical Officer, effective July 8, 2019 [...]
Nationally Recognized Medical Experts Join Receptor Life Science’s Scientific Advisory Board to Guide the Development of New Cannabinoid Therapies
24/06/2019
SEATTLE, June 24, 2019 (GLOBE NEWSWIRE) -- Receptor Life Sciences (RLS), a leader in FDA-regulated cannabinoid medicine drug development using proprietary delivery technologies, today announced the formation of its [...]
electroCore Announces gammaCore(TM) Listing on the NHS Supply Chain Catalogue
24/06/2019
LONDON, and BASKING RIDGE, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore TM , the company’s [...]
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103
24/06/2019
Safety data from all patients show that KB103 was well tolerated with no adverse events reported Five out of six wounds treated with KB103 in the Phase 2 trial closed 100% during the trial The average time to complete [...]
Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress
24/06/2019
DURHAM, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Company will present four abstracts with data from studies of avatrombopag in patients with chronic immune [...]

Pages